Does Nomura Asset Management own CYTK stock?

Yes. As of its Q2 2026 13F, Nomura Asset Management holds 0 shares of CYTK (Cytokinetics).

How many shares of CYTK does Nomura Asset Management own?

As of its Q2 2026 13F, Nomura Asset Management holds 0 shares of CYTK (Cytokinetics).

Nomura Asset Management first reported CYTK in its Q4 2020 13F and has listed it in 23 quarterly 13F filings.

Showing 8 of 23 quarters

Position history for NANomura Asset Management Co. Ltd.'s holdings in Cytokinetics, Incorporated

Current Value

Current Shares

Total Value Change

Total Shares Change

Quarter-by-Quarter History

Quarter	Action	Change	Value	Weight	Price
2026-Q2 Latest	Unchanged	—	$0	0.0%	$85.19
2026-Q1	Unchanged	—	$0	0.0%	$65.91
2025-Q4	Unchanged	—	$0	0.0%	$63.54
2025-Q3	Unchanged	—	$0	0.0%	$54.96
2025-Q2	Unchanged	—	$0	0.0%	$33.04
2025-Q1	Unchanged	—	$0	0.0%	$40.19
2024-Q4	Unchanged	—	$0	0.0%	$47.04
2024-Q3	Unchanged	—	$0	0.0%	$52.80